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  9 
Summary 10 
Standardized gene naming is crucial for effective communication about genes, and as 11 
genomics becomes increasingly important in healthcare, the need for a consistent language 12 
for human genes becomes ever more vital. Here we present the current HUGO Gene 13 
Nomenclature Committee (HGNC) guidelines for naming not only protein-coding but also RNA 14 
genes and pseudogenes, and outline the changes in approach and ethos that have resulted 15 
from the discoveries of the last few decades. 16 
 17 
Introduction 18 
The first guidelines for human gene nomenclature were published in 19791, when the Human 19 
Gene Nomenclature Committee was originally established and charged with the authority to 20 
approve and implement standardized human gene symbols and names. In 1989 the 21 
Nomenclature Committee was placed under the auspices of the newly founded Human 22 
Genome Organisation (HUGO), becoming the HUGO Gene Nomenclature Committee (HGNC). 23 
Subsequent revisions to the nomenclature guidelines were published in 19872,19953, 19974, 24 
and 20025. In the intervening years the HGNC has published online updates to the guidelines 25 
to reflect the significant changes and increase in knowledge and data during this exciting 26 
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period in human genomics. Over 40,000 human loci have been named by the HGNC to date; 27 
around half are protein-coding genes, and most resources now agree that there are around 28 
19,000-20,000 protein-coding genes in the human genome, considerably lower than some 29 
earlier estimates. As well as naming protein-coding genes, significant progress has been 30 
made in different classes of RNA genes and pseudogenes. All approved human gene symbols 31 
can be found in the online HGNC database (https://www.genenames.org/)6. 32 
The philosophy of the HGNC used to be that “gene nomenclature should evolve with new 33 
technology” and that symbol changes, if supported by most researchers working on a gene, 34 
were considered if they reflected new functional information. Since the advent of clinical 35 
genomics such changes have much wider impacts, and it is impossible to reach all clinicians, 36 
patients, charities and other parties interested in genes. Therefore, the stability of gene 37 
symbols, particularly those associated with disease, is now a key priority for the HGNC. 38 
Nevertheless, novel information can still be encapsulated in the gene name without changing 39 
the gene symbol. 40 
As human gene symbols are also routinely transferred to homologous vertebrate genes, 41 
including in our sister project the Vertebrate Gene Nomenclature Committee (VGNC), we now 42 
avoid references to human-specific traits in nomenclature wherever possible. 43 
We strongly advise researchers to contact us whenever they are considering naming a novel 44 
gene, or renaming an existing gene or group of genes, of all locus types, not only for protein-45 
coding genes. It is not always possible to approve the symbol requested, but we strive to 46 
work with researchers to find an acceptable alternative. Requesting an approved symbol 47 
ensures that your published symbol is present in our and other biomedical databases. We 48 
further encourage journal editors and reviewers to check that approved nomenclature is 49 
being used and require that authors contact the HGNC prior to publication for any novel 50 
symbols. Submitters should bear in mind that the HGNC is committed to minimal future 51 
changes to gene symbols and that we do not take publication precedence into account when 52 
approving nomenclature.      53 
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Readers should note that the following are guidelines and recommendations (Box 1), not 54 
strict rules. We are aware of numerous exceptional legacy symbols and names that remain 55 
approved. The HGNC considers the naming of each and every gene on a case-by-case basis, 56 
and deviations from these guidelines may be made given sufficient evidence that the 57 
nomenclature will ultimately aid communication and data retrieval.  58 
 59 
Gene naming 60 
For many years the HGNC has maintained the definition of a gene as "a DNA segment that 61 
contributes to phenotype/function. In the absence of demonstrated function a gene may be 62 
characterized by sequence, transcription or homology". As there is still no universally agreed 63 
alternative we continue to use this definition.  64 
Ideally gene symbols are short, memorable and pronounceable, and most gene names are 65 
long form descriptions of the symbol. Names should be brief, specific and convey something 66 
about the character or function of the gene product(s), but not attempt to describe 67 
everything known. Each gene is assigned only one symbol; the HGNC does not routinely 68 
name isoforms (i.e. alternate transcripts or splice variants). This means no separate symbols 69 
for protein-coding or non-coding RNA isoforms of a protein-coding locus or alternative 70 
transcripts from a non-coding RNA locus (Box 2). 71 
Where authors wish to use their own isoform notation, we advise stating clearly that this 72 
notation denotes an isoform of a particular gene and quoting the HGNC symbol for that gene. 73 
In exceptional circumstances, and following community demand, separate symbols have been 74 
approved for gene segments in complex loci, i.e. the UGT1 locus, the clustered 75 
protocadherins at 5q31 and the immunoglobulin and T cell receptor families. Putative 76 
bicistronic loci may be assigned separate symbols to represent the distinct gene products. For 77 
example, PYURF, “PIGY upstream reading frame” is encoded by the same transcript as PIGY, 78 
“phosphatidylinositol glycan anchor biosynthesis class Y”.     79 
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Table 1 summarizes key factors considered when assigning gene nomenclature. Additionally, 80 
Supplementary table 1 lists characters recommended for specific usage in symbols, 81 
Supplementary table 2 highlights specific conventions used in gene names, and 82 
Supplementary tables 3 and 4 provide Greek-to-Latin alphabet conversions and single letter 83 
amino acid symbols, respectively.  84 
 85 
Gene naming by biotype 86 
Protein-coding genes 87 
We aim to name protein-coding genes based on a key normal function of the gene product. 88 
Many protein-coding genes of known function are named in collaboration with internationally 89 
recognized bodies composed of experts in a specific field. Where possible, related genes are 90 
named using a common root symbol to enable grouping, typically based on sequence 91 
homology, shared function or membership of protein complexes.  92 
Gene group members should be designated by Arabic numerals placed immediately after the 93 
root symbol, e.g. KLF1, KLF2, KLF3. More rarely single-letter suffixes may be used, e.g. 94 
LDHA, LDHB, LDHC. Some large gene families may include a variety of number/letter 95 
combinations to indicate subgroupings, e.g. CYP1A1, CYP21A2, CYP51A1 (cytochrome P450 96 
superfamily members). 97 
For genes involved in specific immune processes, or encoding an enzyme, receptor or ion 98 
channel, we consult with specialist nomenclature groups (see Supplementary Note). For other 99 
major gene groups we consult a panel of advisors when naming new members and discussing 100 
proposed nomenclature updates. A list of our specialist advisors is provided on our website6 101 
and we welcome suggestions of new experts for specific gene groups. 102 
In the absence of functional data, protein-coding genes may be named in the following ways: 103 
(1) Based on recognized structural domains and motifs encoded by the gene (e.g. ABHD1 104 
“abhydrolase domain containing 1”, HEATR1 “HEAT repeat containing 1”). As these features 105 
can provide insight into the character of the gene product, this type of symbol is commonly 106 
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retained even after the normal function of the gene product has been elucidated, though 107 
further information may be added to the gene name; (2) Based on homologous genes within 108 
the human genome. Where naming is based on characterized homologs, genes of unknown 109 
function are given the next symbol within a designated series but with a different gene name 110 
format, e.g. CASTOR3, "CASTOR family member 3" rather than "cytosolic arginine sensor for 111 
mTORC1 subunit 3". The placeholder root symbol FAM (“family with sequence similarity”) is 112 
used when there is no information available for any of the homologous genes. Each 113 
homologous family has a unique FAM number, e.g. FAM3, and each family member is 114 
distinguished by a letter or letter and number, e.g. FAM3A, FAM3C2P. Note that this root can 115 
be applied to both protein-coding and non-coding gene families; (3) Based on homologous 116 
genes from another species. Where there is a 1-to-1 ortholog, the same/equivalent symbol 117 
will be approved, e.g. human CDC45 “cell division cycle 45” based on S. cerevisiae CDC45. A 118 
unique number or letter suffix is added if there is more than one human homolog, e.g. 119 
UNC45A and UNC45B are co-orthologs of C. elegans unc-45. Gene names are updated to be 120 
appropriate for vertebrates, e.g. "unc-45 myosin chaperone" instead of "UNCoordinated 45"; 121 
(4) Based only on the presence of an open reading frame. Genes of unknown function that fit 122 
none of the above criteria are designated by the chromosome of origin, the letters "orf" for 123 
open reading frame (in lower case to prevent confusion between "O" and the numeral "0", 124 
which may be part of the chromosome number) and a number in a series, e.g. C3orf18, 125 
"chromosome 3 open reading frame 18". In cases where the coding potential of the locus is in 126 
doubt we include the word “putative” in the name, e.g. “chromosome 18 putative open 127 
reading frame 15”. 128 
Historically, genes of unknown function identified by the Human cDNA project at the Kazusa 129 
DNA Research Institute10 have been named using the KIAA# identifiers assigned by this 130 
project.  131 
Pseudogenes 132 
We define a pseudogene as a sequence that is incapable of producing a functional protein 133 
product but has a high level of homology to a functional gene. In general, we only name 134 
pseudogenes that retain homology to a significant proportion of the functional ancestral gene. 135 
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The majority of pseudogenes are processed and named based on a specific parent gene, e.g. 136 
DPP3P1, “DPP3 pseudogene 1”. Such pseudogene numbering is usually species-specific and 137 
hence orthology cannot be inferred from identical pseudogene symbols in different species.  138 
 Pseudogenes that retain most of the coding sequence compared to other family members 139 
(and are usually unprocessed) are named as a new family member with a “P” suffix, e.g. 140 
CBWD4P, “COBW domain containing 4, pseudogene”. This naming format is also used for 141 
genes that are pseudogenized relative to their functional ortholog in another species, e.g. 142 
ADAM24P, “ADAM metallopeptidase domain 24, pseudogene” is the pseudogenized ortholog 143 
of mouse Adam24. Note, rarely such pseudogenes do not include the “P” if the symbol is well 144 
established, e.g. UOX, “urate oxidase (pseudogene)”.  145 
A small number of genes are currently pseudogenized in the reference genome, but known to 146 
have coding alleles segregating in the population. Such loci are given the locus type “protein-147 
coding” and indicated by including “(gene/pseudogene)” at the end of the gene name, e.g. 148 
CASP12, “caspase 12 (gene/pseudogene)”.       149 
Non-coding RNA genes 150 
We name non-coding RNA (ncRNA) genes according to their RNA type, please see our recent 151 
review11. For small RNAs where an expert resource exists, we follow their naming schema, 152 
e.g. miRBase12 for microRNAs and the genomic tRNA database (GtRNAdb)13 for tRNAs. Other 153 
classes of ncRNA such as small nuclear RNAs are named in collaboration with specialist 154 
advisors. 155 
For long non-coding RNAs (lncRNAs), wherever possible we name these based on a key 156 
function or characteristic of the encoded RNA. Where functional information is not available, a 157 
systematic nomenclature is applied, see Figure 1.   158 
Readthrough transcripts 159 
Readthrough transcripts are normally produced from adjacent loci and include coding and/or 160 
non-coding parts of two (or more) genes. The HGNC only names readthrough transcripts      161 
that are consistently annotated by both the RefSeq annotators at NCBI14 and the GENCODE 162 
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annotators at Ensembl15. These transcripts have the locus type “readthrough transcript” and 163 
are symbolized using the two (or more) symbols from the parent genes, separated by a 164 
hyphen, e.g. INS-IGF2, and the name “[symbol] readthrough”, e.g. “INS-IGF2 readthrough”. 165 
The name may also include additional information about the potential coding status of the 166 
transcript, such as “(NMD candidate)”. 167 
Gene segments 168 
For specific complex loci the HGNC assigns symbols to individual gene segments, solely based 169 
on community request. Examples of this are the immunoglobulins and T-cell receptors, the 170 
UGT1 locus and clustered protocadherins.  171 
Genomic regions 172 
The HGNC previously named genomic regions referenced in the literature, such as XIC, “X 173 
chromosome inactivation center”, and gene clusters were assigned symbols suffixed with the 174 
“@” character, e.g. HOXA@, “homeobox A cluster”. We no longer routinely provide symbols 175 
for genomic regions but some, such as those for fragile sites, have been retained where they 176 
have been used in publications and this information would otherwise be lost.  177 
 178 
Genes only found within subsets of the population 179 
Historically, the HGNC has only approved symbols for genes that are on the human reference 180 
genome. Rare exceptions have been made when requested by particular communities, e.g. 181 
structural variants within the HLA and KIR gene families, both of which have dedicated 182 
nomenclature committees. Future naming of structural variants will be restricted to those on 183 
alternate loci that have been incorporated into the human reference genome by the Genome 184 
Reference Consortium (GRC, https://www.ncbi.nlm.nih.gov/grc). The underscore character is 185 
reserved for genes annotated on alternate reference loci, e.g. GTF2H2C_2 is a second copy of 186 
GTF2H2C on a 5q13.2 alternate reference locus; APOBEC3A_B is a deletion hybrid on a 187 
22q13 alternate reference locus that includes exons from both the APOBEC3A and APOBEC3B 188 





All HGNC gene records have a status: the vast majority are “approved”, but when new 192 
evidence shows that a previously named gene is no longer considered to be real the entry 193 
changes to the status “entry withdrawn”. Wherever possible we avoid reusing symbols from 194 
“entry withdrawn” records, as this can cause considerable confusion. 195 
 196 
Naming across vertebrates 197 
We recommend that orthologous genes across vertebrate (and where appropriate, non-198 
vertebrate) species should have the same gene symbol.  199 
The Vertebrate Gene Nomenclature Committee  200 
The Vertebrate Gene Nomenclature Committee (VGNC, https://vertebrate.genenames.org/) is 201 
an extension of the HGNC responsible for assigning standardized names to genes in 202 
vertebrate species that currently lack a nomenclature committee. The VGNC coordinates with 203 
the five established existing vertebrate nomenclature committees, MGNC (mouse)16, RGNC 204 
(rat, https://rgd.mcw.edu/nomen/nomen.shtml), CGNC (chicken)17, XNC (Xenopus frog)18 205 
and ZNC (zebrafish)19, to ensure vertebrate genes are named in line with their human 206 
homologs. 207 
Orthologs of human C#orf# genes are assigned the human symbol with the other species 208 
chromosome number as a prefix and an H denoting human. Therefore, as the ortholog of 209 
human C1orf100 is on cow chromosome 16, the cow symbol is C16H1orf100 with the 210 
corresponding gene name "chromosome 16 C1orf100 homolog". 211 
Gene families with a complex evolutionary history should ideally be named with the help of 212 
an expert in the field, as has already been implemented for the olfactory receptor20 and 213 
cytochrome P450 gene families. 214 
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Species designation 215 
To distinguish the species of origin for homologous genes with the same gene symbol, we 216 
recommend citing the NCBI taxonomy ID21, as well as either the current name or the  217 
GenBank common name, e.g. Taxonomy ID: 9598 and either Pan troglodytes or chimpanzee. 218 
 219 
Nomenclature updates 220 
While we are committed to minimizing symbol changes some updates will still be appropriate. 221 
All requests for change are considered on a case-by-case basis and often involve community 222 
consultation. We anticipate most future changes will fall into one of the following categories. 223 
Symbol updates for placeholders 224 
FAMs, C#orfs and KIAAs are regarded as placeholder symbols and updated with structure 225 
and/or function-based designations whenever possible. However, where specific placeholder 226 
symbols have become entrenched in the literature, we may make exceptions and retain the 227 
placeholder, while updating the gene name, e.g. FAM20B has been retained with the updated 228 
gene name FAM20B glycosaminoglycan xylosylkinase.  229 
Replacing underused and problematic nomenclature  230 
We may consider updating symbols that have been rarely/never published, are not suitable 231 
for transfer to other vertebrates, and/or have been widely used but could cause significant 232 
problems. Examples are shown in Box 3.  233 
 234 
Gene symbol usage 235 
The HGNC endorses the use of italics to denote genes, alleles and RNAs to distinguish them 236 
from proteins.  237 
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We advise that authors quote the approved gene symbol at least once in the abstract of any 238 
publication. Every gene with an approved symbol also has a unique HGNC ID in the format 239 
HGNC:number (e.g. gene symbol BRAF, HGNC ID HGNC:1097). While we aim to minimize 240 
symbol changes some updates are inevitable and sometimes an approved symbol can be 241 
used to denote a different gene in the literature; therefore we advise quoting the HGNC ID 242 
for each gene to avoid ambiguity. HGNC IDs are associated with the gene sequence and do 243 
not change unless the gene structure undergoes extreme alteration (i.e. merged with another 244 
locus or split into multiple loci). This ensures effective and reliable tracking of data regardless 245 
of any nomenclature changes.  246 
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Figure 1: The HGNC has a systematic process for naming long non-coding (lnc)RNA genes. In the 307 
absence of suitable published information, lncRNA genes are named based on genomic context. 308 
Abbreviations are as follows: HG: host gene, PC: protein-coding, DT: divergent transcript (used for 309 
lncRNA genes that share a promoter with a PC gene), IT: intronic transcript, OT: overlapping transcript, 310 
AS: antisense RNA, LINC: long intergenic non-protein coding RNA. 311 
 312 
Table 1 313 
Symbols Names 
Must be unique within a given genome Should be brief and specific 
Must not be offensive or pejorative (ideally in any language) 
Must not use superscripts or subscripts 
or punctuation* 
Should minimize punctuation; commas, hyphens 
and parentheses are included for clarity** 
Must only contain uppercase*** Latin 
letters and Arabic numerals  
Must be written in American English  
Must start with a letter Must start with a lowercase letter (unless 
starting with an eponymous term or capitalised 
abbreviation) 
Should not include “G” for gene, “H” for 
human, Roman numerals or Greek letters 
Should not include the words “gene” or “human” 
Should not spell proper names or common 
words or match commonly used abbreviations 
Should start with the same letter as the symbol 
(to facilitate alphabetical listing and grouping) 
Should avoid duplicating symbols in other 
species (unless orthologous) 
Should not reference: any species, taxa, tissue 
specificity, molecular weight, chromosomal 
location, human-specific features and 
phenotypes, familial terms 
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Some letters or combinations of letters are 
used in a symbol to give a specific meaning, 
and their use for other meanings should be 
avoided where possible (see supplementary 
table 1). 
Descriptive modifiers usually follow the main 
part of the name, to enable the use of a 
common root symbol for a gene group, e.g. 
ACADM "acyl-CoA dehydrogenase medium 
chain" and ACADS "acyl-CoA dehydrogenase 
short chain". 
* see Supplementary Table 2 for punctuation exceptions in symbols 314 
** exceptions on punctuation are made for enzyme names  315 
*** sole exception of C#orfs 316 
 317 
Box 1: 318 
A summary of the guidelines is: 319 
1. Each gene is assigned a unique symbol, HGNC ID and descriptive name. 320 
2. Symbols contain only uppercase Latin letters and Arabic numerals. 321 
3. Symbols should not be the same as commonly used abbreviations 322 
4. Nomenclature should not contain reference to any species or "G" for gene. 323 
5. Nomenclature should not be offensive or pejorative. 324 
 325 
Box 2: 326 
HGNC does not provide official nomenclature for the following: 327 
sequence variant nomenclature, which is the responsibility of the Human Genome 328 
Variation Society (HGVS)7. They provide recommendations for defining variations found in 329 
DNA, RNA and protein sequences, and endorse the use of HGNC gene symbols within their 330 
notation.            331 
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products of gene translocations or fusions: we are not aware of official naming 332 
guidelines for these. SYMBOL1-SYMBOL2 is widely used, but we use this format for 333 
readthrough transcripts (see section 2.4) and hence would specifically not recommend this 334 
for translocations or fusions. We recommend the format SYMBOL1/SYMBOL2, which has 335 
been used in some publications, e.g. BCR/ABL1. 336 
protein nomenclature: we have no authority over naming proteins, but coordinate closely 337 
with specialist groups who name specific subsets of proteins, such as the Enzyme 338 
Commission. The recently devised International Protein Nomenclature Guidelines 339 
(https://www.ncbi.nlm.nih.gov/genome/doc/internatprot_nomenguide/) were written with 340 
the involvement of the HGNC, and in agreement with these guidelines we recommend that 341 
“protein and gene symbols should use the same abbreviation”.  We further advise that 342 
proteins are referenced using non-italicised gene symbols, to distinguish them from genes.  343 
nomenclature for regulatory genomic elements such as promoters, enhancers and 344 
transcription factor binding sites. We also do not provide nomenclature for transposable 345 
element insertions in the human genome. Protein-coding and long non-coding RNA genes 346 
that fit the criteria outlined in Mayer et al.8 may be named as ERV-derived genes, but ERV 347 
insertions will not be named. 348 
nomenclature for human loci associated with clinical phenotypes and complex 349 
traits. While HGNC historically named these, this activity has been taken over by OMIM9. All 350 
HGNC entries with the locus type “phenotype only” now have the status “entry withdrawn”. 351 
Note that some uncharacterized genes shown to be causative for a specific phenotype 352 
adopted the phenotype symbol and name. Where these phenotypic symbols have become 353 
entrenched in the literature, we aim to update the corresponding gene names to reflect an 354 
aspect of the normal function of the gene and its products, e.g. TSC1, “tuberous sclerosis 1” 355 
is now TSC1, “TSC complex subunit 1”.  356 
 357 
Box 3:  358 
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Scenarios that may merit a symbol change include: 359 
• adoption of a more appropriate/popular alias, e.g. RNASEN was updated to 360 
DROSHA (drosha ribonuclease III) due to overwhelming community usage. 361 
• domain or motif-based nomenclature, e.g. TMEM206 (transmembrane protein 362 
206) is now PACC1 (proton activated chloride channel 1). 363 
• phenotype/disease-based nomenclature, e.g. CASC4 (cancer susceptibility 364 
candidate 4) was renamed GOLM2 (golgi membrane protein 2), consistent with its 365 
paralog GOLM1. 366 
• location-based nomenclature, e.g. TWISTNB (TWIST neighbour) is now POLR1F 367 
(RNA polymerase I subunit F).  368 
• pejorative symbols, e.g. DOPEY1 was renamed to DOP1A (DOP1 leucine zipper like 369 
protein A). 370 
• misleading/incorrect nomenclature, e.g. OTX3 was initially named erroneously as 371 
an OTX family member and has been renamed as DMBX1 372 
(diencephalon/mesencephalon homeobox 1). 373 
• symbols that affect data handling and retrieval, e.g. all symbols that auto-374 
converted to dates in Microsoft Excel have been changed (SEPT1 is now SEPTIN1; 375 
MARCH1 is now MARCHF1 etc); tRNA synthetase symbols that were also common 376 
words have been changed (WARS is now WARS1, CARS is now CARS1, etc.). 377 
 378 
 379 
 380 
 381 
